The prescribing information for both semaglutide (Wegovy) and tirzepatide (Zepbound) includes warnings about the risk of acute kidney injury, particularly in patients who experience severe adverse gastrointestinal reactions
the National Institute of Diabetes and Digestive and Kidney Diseases notes that the body responds to weight loss by lowering its calorie needs, which can slow the pace of further loss (NIDDK: Factors Affecting Weight & Health)
Higher purity directly translates to better results when used in glutathione tablets for skin
Lancet Diabetes Endocrinol 5(4):271279 Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF, STEP 1 Study Group (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
For type 2 diabetes, it is indicated as an adjunct to diet and exercise to improve glycaemic control